Wealth Enhancement Advisory Services
ABBV icon

Wealth Enhancement Advisory Services’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$105M Buy
554,650
+18,200
+3% +$3.44M 0.17% 116
2025
Q1
$112M Buy
536,450
+12,085
+2% +$2.53M 0.22% 89
2024
Q4
$93.2M Sell
524,365
-31,930
-6% -$5.67M 0.18% 115
2024
Q3
$110M Buy
556,295
+104,454
+23% +$20.6M 0.24% 81
2024
Q2
$77.5M Buy
451,841
+27,103
+6% +$4.65M 0.18% 110
2024
Q1
$77.3M Buy
424,738
+32,732
+8% +$5.96M 0.2% 106
2023
Q4
$60.7M Sell
392,006
-49,324
-11% -$7.64M 0.18% 126
2023
Q3
$65.8M Buy
441,330
+413,330
+1,476% +$61.6M 0.22% 102
2023
Q2
$3.77M Sell
28,000
-3,912
-12% -$527K 0.04% 147
2023
Q1
$5.09M Buy
+31,912
New +$5.09M 0.06% 133
2022
Q4
Sell
-44,537
Closed -$6.18M 317
2022
Q3
$6.18M Buy
44,537
+30,880
+226% +$4.28M 0.09% 106
2022
Q2
$2.09M Buy
13,657
+12,072
+762% +$1.85M 0.03% 200
2022
Q1
$257K Sell
1,585
-317
-17% -$51.4K ﹤0.01% 294
2021
Q4
$260K Sell
1,902
-3,546
-65% -$485K ﹤0.01% 280
2021
Q3
$596K Buy
5,448
+3
+0.1% +$328 0.01% 243
2021
Q2
$638K Buy
5,445
+119
+2% +$13.9K 0.01% 219
2021
Q1
$561K Buy
5,326
+504
+10% +$53.1K 0.01% 225
2020
Q4
$533K Sell
4,822
-34,928
-88% -$3.86M 0.01% 192
2020
Q3
$3.51M Buy
39,750
+5,036
+15% +$445K 0.09% 79
2020
Q2
$3.39M Buy
34,714
+605
+2% +$59.1K 0.1% 79
2020
Q1
$2.82M Buy
+34,109
New +$2.82M 0.1% 88
2019
Q2
Sell
-21,343
Closed -$1.68M 198
2019
Q1
$1.68M Buy
21,343
+4,833
+29% +$380K 0.09% 90
2018
Q4
$1.48M Sell
16,510
-17,069
-51% -$1.53M 0.09% 81
2018
Q3
$2.67M Sell
33,579
-8,579
-20% -$681K 0.16% 46
2018
Q2
$4.09M Buy
42,158
+34,000
+417% +$3.3M 0.25% 39
2018
Q1
$752K Buy
8,158
+4,180
+105% +$385K 0.05% 131
2017
Q4
$399K Buy
+3,978
New +$399K 0.03% 134